Moss Jonathan, Christie Andrew
Department of Interventional Radiology, Queen Elizabeth University NHS Hospital Glasgow, 1345 Govan Rd, Govan, Glasgow, G51 4TF, UK.
Womens Health (Lond). 2016 Jan;12(1):71-7. doi: 10.2217/whe.15.78. Epub 2016 Jan 12.
Uterine artery embolization (UAE) as a treatment option for fibroids was first reported by Ravina in 1995. Although rapidly adopted by enthusiasts, many were skeptical and its introduction varied widely across the globe. It was not until randomized controlled trials and registries were published and national guidance statements issued that UAE was accepted as a safe and proven treatment for fibroids. The technique is now established as one of the treatment options to be discussed with patients as an alternative to surgery for fibroid-associated heavy menstrual bleeding. Research is on-going to evaluate the relative merits of UAE compared with other medical and surgical treatment options for heavy menstrual bleeding, particularly for women wishing to maintain their fertility.
子宫动脉栓塞术(UAE)作为子宫肌瘤的一种治疗选择,最早于1995年由拉维纳报道。尽管很快被热心者采用,但许多人持怀疑态度,其引入在全球各地差异很大。直到随机对照试验和登记处公布,以及国家指导声明发布后,UAE才被公认为是一种安全且经过验证的子宫肌瘤治疗方法。该技术现已成为与患者讨论的治疗选择之一,可作为子宫肌瘤相关月经过多的手术替代方案。目前正在进行研究,以评估UAE与其他治疗月经过多的药物和手术选择相比的相对优点,特别是对于希望保持生育能力的女性。